Chemspec Europe 2018 - The 33rd International Exhibition for Fine & Speciality Chemicals
Chemspec Europe is a renowned market place for sourcing and trading of fine and speciality chemicals for a wide range of applications and industry sectors, including pharmaceuticals and bio-based chemicals.
With its combination of an international exhibition, a comprehensive conference programme, targeted networking events as well as a new Partnering Programme, Chemspec Europe 2018 offers visitors a unique opportunity to source products, find business partners and keep up-to-date with the latest findings in R&D.
The pharma conference themes at this year’s event include:
– The Pharma Panel on Outsourcing Best Practices will be of interest to a wide audience from Pharma, Crop Protection and Chemical companies, CROs and CMOs who are engaged in contract research and custom synthesis of Active Pharmaceutical Ingredients (API). The sessions will discuss approaches to developing global outsourcing strategies, identifying outsourcing partners, identifying approaches to mitigate risks, and addressing challenges associated with outsourcing and how to effectively manage partnerships.
– The Abou-Gharbia Lecture Theatre will focus on “Drug Discovery, Then and Now: The Road to Personalized Medicine” by Dr. Magid Abou-Gharbia, Moulder Center for Drug Discovery Research, School of pharmacy, Temple University, Philadelphia, PA, USA. The presentation will cover the themes “Discovery of Small Molecule Therapeutics”, “Companion Diagnostics and Targeted Therapies for Cancer” and “Precision Medicine’s Impact on Pharma and Health Care, Challenges and Future Opportunities.”
Contact Details:
Chemspec Europe 2018 - The 33rd International Exhibition for Fine & Speciality Chemicals
Date: 20th – 21st June 2018,
Venue: Koelnmesse, Cologne, Germany
Contact: info@chemspeceurope.com
URL: http://www.chemspeceurope.com/
Registration: https://chemspec.ticketstore-online.de/vrvisitor/?langid=EN
Guidance on Quality Culture Standards
June 3rd 2025Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs Company, discuss PDA/ANSI Standard 06-2025: Assessment of Quality Culture Guidance Documents, Models, and Tools, which was published in February 2025.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
